PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 4,080.00
-5.00 (-0.12%)
Feb 19, 2026, 9:19 AM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 89.51 billion as of February 18, 2026. Its market cap has increased by 9.06% in one year.
Market Cap
89.51B
Enterprise Value
94.86B
Revenue
171.66B
Ranking
n/a
PE Ratio
760.20
Stock Price
4,080.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 89.51B, an increase of 721.83%. That is a compound annual growth rate of 7.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 89.51B | -1.68% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.16T |
| Celltrion | 52.09T |
| ALTEOGEN | 20.43T |
| Sam Chun Dang Pharm. | 12.44T |
| Oncocross | 96.41B |
| Cellid, | 95.00B |
| Sugentech | 93.57B |
| Kukje Pharma | 91.43B |